Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 52 results.
User Information
Export Records
  1. 1.   Innate Immune Stimulation Using 3D Wireframe DNA Origami
  2. Du, Rebecca R; Cedrone,Edward; Romanov, Anna; Falkovich, Reuven; Dobrovolskaia,Marina; Bathe, Mark
  3. ACS Nano. 2022, Dec 02;
  1. 2.   CpG Site-Specific Methylation-Modulated Divergent Expression of PRSS3 Transcript Variants Facilitates Nongenetic Intratumor Heterogeneity in Human Hepatocellular Carcinoma
  2. Lin, Shuye; Xu, Hanli; Pang, Mengdi; Zhou, Xiaomeng; Pan, Yuanming; Zhang, Lishu; Guan, Xin; Wang, Xiaoyue; Lin, Bonan; Tian, Rongmeng; Chen,Keqiang; Zhang, Xiaochen; Yang, Zijiang; Ji, Fengmin; Huang, Yingying; Wei, Wu; Gong,Wang; Ren, Jianke; Wang,Jiming; Guo, Mingzhou; Huang, Jiaqiang
  3. Frontiers in Oncology. 2022, Apr 11; 12: 831268.
  1. 3.   Evaluation of the AV7909 Anthrax Vaccine Toxicity in Sprague Dawley Rats Following Three Intramuscular Administrations
  2. Rao, Veena V; Godin, C Steven; Lacy, Michael J; Inglefield,Jon; Park, Sukjoon; Blauth, Bruna; Reece, Joshua J; Ionin, Boris; Savransky, Vladimir
  3. International journal of toxicology. 2021, Jul 19; 10915818211031239.
  1. 4.   CpG Methylation Profiles of HIV-1 Proviral DNA in Individuals on ART
  2. Boltz,Valerie; Ceriani, Cristina; Rausch,Jason; Shao,Wei; Bale, Michael J.; Keele,Brandon; Hoh, Rebecca; Milush, Jeffrey M.; Deeks, Steve G.; Maldarelli,Frank; Kearney,Mary; Coffin, John M.
  3. VIRUSES-BASEL. 2021, May; 13(5):
  1. 5.   Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue
  2. Shi, J.; Marconett, C. N.; Duan, J.; Hyl, P. L.; Li, P.; Wang, Z.; Wheeler, W.; Zhou, B.; Campan, M.; Lee, D. S.; Huang, J.; Zhou, W.; Triche, T.; Amundadottir, L.; Warner, A.; Hutchinson, A.; Chen, P. H.; Chung, B. S.; Pesatori, A. C.; Consonni, D.; Bertazzi, P. A.; Bergen, A. W.; Freedman, M.; Siegmund, K. D.; Berman, B. P.; Borok, Z.; Chatterjee, N.; Tucker, M. A.; Caporaso, N. E.; Chanock, S. J.; Laird-Offringa, I. A.; Landi, M. T.
  3. Nature Communications. 2014, 27-Feb; 5: 3365.
  1. 6.   Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant
  2. La Rosa, C.; Longmate, J.; Lacey, S. F.; Kaltcheva, T.; Sharan, R.; Marsano, D.; Kwon, P.; Drake, J.; Williams, B.; Denison, S.; Broyer, S.; Couture, L.; Nakamura, R.; Kelsey, M. I.; Krieg, A. M.; Diamond, D. J.; Zaia, J. A.
  3. Journal of Infectious Diseases. 2012, Apr; 205(8): 1294-1304.
  1. 7.   The acceleration of wound healing in primates by the local administration of immunostimulatory CpG oligonucleotides
  2. Yamamoto, M.; Sato, T.; Beren, J.; Verthelyi, D.; Klinman, D. M.
  3. Biomaterials. 2011, Jun; 32(18): 4238-4242.
  1. 8.   Adeno-Associated Viral Vector-Mediated Transgene Expression Is Independent of DNA Methylation in Primate Liver and Skeletal Muscle
  2. Leger, A.; Le Guiner, C.; Nickerson, M. L.; Im, K. M.; Ferry, N.; Moullier, P.; Snyder, R. O.; Penaud-Budloo, M.
  3. Plos One. 2011, Jun; 6(6): 11.
  1. 9.   CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity
  2. Shirota, H.; Klinman, D. M.
  3. Cancer Immunology Immunotherapy. 2011, May; 60(5): 659-669.
  1. 10.   CpG DNA as a vaccine adjuvant
  2. Bode, C.; Zhao, G.; Steinhagen, F.; Kinjo, T.; Klinman, D. M.
  3. Expert Review of Vaccines. 2011, Apr; 10(4): 499-511.
  1. 11.   Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages
  2. Buhtoiarov, I. N.; Sondel, P. M.; Wigginton, J. M.; Buhtoiarova, T. N.; Yanke, E. M.; Mahvi, D. A.; Rakhmilevich, A. L.
  3. Immunology. 2011, Feb; 132(2): 226-239.
  1. 12.   Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumors
  2. Lee, S.; Yagita, H.; Sayers, T. J.; Celis, E.
  3. Cancer Immunology Immunotherapy. 2010, Jul; 59(7): 1073-1081.
  1. 13.   Short- and long-term changes in gene expression mediated by the activation of TLR9
  2. Klaschik, S.; Tross, D.; Shirota, H.; Klinman, D. M.
  3. Molecular Immunology. 2010, Mar; 47(6): 1317-1324.
  1. 14.   DNA Methylation in Early Development
  2. Geiman, T. M.; Muegge, K.
  3. Molecular Reproduction and Development. 2010, Feb; 77(2): 105-113.
  1. 15.   Lsh Mediated RNA Polymerase II Stalling at HoxC6 and HoxC8 Involves DNA Methylation
  2. Tao, Y. G.; Xi, S. C.; Briones, V.; Muegge, K.
  3. Plos One. 2010, Feb; 5(2): e9163.
  1. 16.   Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants
  2. Klinman, D. M.; Klaschik, S.; Tomaru, K.; Shirota, H.; Tross, D.; Ikeuchi, H.
  3. Vaccine. 2010, Feb; 28(8): 1919-1923.
  1. 17.   Accelerated wound healing mediated by activation of Toll-like receptor 9
  2. Sato, T.; Yamamoto, M.; Shimosato, T.; Klinman, D. M.
  3. Wound Repair and Regeneration. 2010, Nov-Dec; 18(6): 586-593.
  1. 18.   A suppressive oligodeoxynucleotide inhibits ocular inflammation
  2. Fujimoto, C.; Klinman, D. M.; Shi, G.; Yin, H.; Vistica, B. P.; Lovaas, J. D.; Wawrousek, E. F.; Igarashi, T.; Chan, C. C.; Gery, I.
  3. Clinical and Experimental Immunology. 2009 156(3): 528-534.
  1. 19.   Defective Plasmacytoid Dendritic Cell-NK Cell Cross-Talk in HIV Infection
  2. Reitano, K. N.; Kottilil, S.; Gille, C. M.; Zhang, X.; Yan, M.; O'Shea, M. A.; Roby, G.; Hallahan, C. W.; Yang, J.; Lempicki, R. A.; Arthos, J.; Fauci, A. S.
  3. Aids Research and Human Retroviruses. 2009 25(10): 1029-1037.
  1. 20.   Contribution of IRF-3 mediated IFN beta production to DNA vaccine dependent cellular immune responses
  2. Shirota, H.; Petrenko, L.; Hattori, T.; Klinman, D. M.
  3. Vaccine. 2009 27(15): 2144-2149.
  1. 21.   Global changes in gene expression and synergistic interactions induced by TLR9 and TLR3
  2. Tross, D.; Petrenko, L.; Klaschik, S.; Zhu, Q.; Klinman, D. M.
  3. Molecular Immunology. 2009 46(13): 2557-2564.
  1. 22.   Tonsillar Application of AT-2 SIV Affords Partial Protection Against Rectal Challenge With SIVmac239
  2. Vagenas, P.; Williams, V. G.; Piatak, M.; Bess, J. W.; Lifson, J. D.; Blanchard, J. L.; Gettie, A.; Robbiani, M.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2009 52(4): 433-442.
  1. 23.   Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mice
  2. Yoo, C. B.; Chuang, J. C.; Byun, H. M.; Egger, G.; Yang, A. S.; Dubeau, L.; Long, T.; Laird, P. W.; Marquez, V. E.; Jones, P. A.
  3. Cancer Prevention Research. 2008 1(4): 233-240.
  1. 24.   Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells
  2. Reinhold, W. C.; Reimers, M. A.; Maunakea, A. K.; Kim, S.; Lababidi, S.; Scherf, U.; Shankavaram, U. T.; Ziegler, M. S.; Stewart, C.; Kouros-Mehr, H.; Cui, H. M.; Dolginow, D.; Scudiero, D. A.; Pommier, Y. G.; Munroe, D. J.; Feinberg, A. P.; Weinstein, J. N.
  3. Molecular Cancer Therapeutics. 2007, Feb; 6(2): 391-403.
  1. 25.   Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia
  2. So, K. J.; Tamura, G.; Honda, T.; Homma, N.; Waki, T.; Togawa, N.; Nishizuka, S.; Motoyama, T.
  3. Cancer Science. 2006, Nov; 97(11): 1155-1158.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel